Dipasquale V, Cicala G, Spina E, Romano C. A Narrative review on efficacy and safety of proton pump inhibitors in children. Front Pharmacol. 2022;13: 839972.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jaynes M, Kumar AB. The risks of long-term use of proton pump inhibitors: a critical review. Ther Adv Drug Saf. 2019;10:2042098618809927.

Article  PubMed  Google Scholar 

Takeda Pharmaceuticals America I. Prevacid (lansoprazole) package insert (US). 2017. https://content.takeda.com/?contenttype=PI&product=PRVAC&language=ENG&country=GBL&documentnumber=1.

Koebnick C, Getahun D, Smith N, Porter AH, Der-Sarkissian JK, Jacobsen SJ. Extreme childhood obesity is associated with increased risk for gastroesophageal reflux disease in a large population-based study. Int J Pediatr Obes. 2011;6(2–2):e257–63.

Article  PubMed  Google Scholar 

Brill MJ, Diepstraten J, van Rongen A, van Kralingen S, van den Anker JN, Knibbe CA. Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012;51(5):277–304.

Article  CAS  PubMed  Google Scholar 

Chen K, Luo P, Yang G, Zhu S, Deng C, Ding J, et al. Population pharmacokinetics of omeprazole in obese and normal-weight adults. Expert Rev Clin Pharmacol. 2022;15(4):461–71.

Article  CAS  PubMed  Google Scholar 

Dunlap TC, Gonzalez D, Kyler KE, Helfer VE, Williams V, Friesen CS, et al. Evaluation of obesity-related physiological changes on pantoprazole clearance in children using a population pharmacokinetic approach. J Clin Pharmacol. 2024;65:108–20.

Article  Google Scholar 

Shakhnovich V, Abdel-Rahman S, Friesen CA, Weigel J, Pearce RE, Gaedigk A, et al. Lean body weight dosing avoids excessive systemic exposure to proton pump inhibitors for children with obesity. Pediatr Obes. 2019. https://doi.org/10.1111/ijpo.12459.

Article  PubMed  Google Scholar 

Shakhnovich V, Brian Smith P, Guptill JT, James LP, Collier DN, Wu H, et al. A population-based pharmacokinetic model approach to pantoprazole dosing for obese children and adolescents. Paediatr Drugs. 2018;20(5):483–95.

Article  PubMed  PubMed Central  Google Scholar 

Litalien C, Theoret Y, Faure C. Pharmacokinetics of proton pump inhibitors in children. Clin Pharmacokinet. 2005;44(5):441–66.

Article  CAS  PubMed  Google Scholar 

Landes BD, Petite JP, Flouvat B. Clinical pharmacokinetics of lansoprazole. Clin Pharmacokinet. 1995;28(6):458–70.

Article  CAS  PubMed  Google Scholar 

Sakurai Y, Hirayama M, Hashimoto M, Tanaka T, Hasegawa S, Irie S, et al. Population pharmacokinetics and proton pump inhibitory effects of intravenous lansoprazole in healthy Japanese males. Biol Pharm Bull. 2007;30(12):2238–43.

Article  CAS  PubMed  Google Scholar 

Al-Sallami HS, Goulding A, Grant A, Taylor R, Holford N, Duffull SB. Prediction of fat-free mass in children. Clin Pharmacokinet. 2015;54(11):1169–78.

Article  CAS  PubMed  Google Scholar 

Lima JJ, Thomas CD, Barbarino J, Desta Z, Van Driest SL, El Rouby N, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing. Clin Pharmacol Ther. 2021;109(6):1417–23.

Article  PubMed  Google Scholar 

U.S. Food and Drug Administration. Bioanalytical method validation guidance for industry. Silver Spring: U.S. Food and Drug Administration; 2018.

Google Scholar 

Beal S, Sheiner L, Boeckmann A, Bauer R. NONMEM 7.4 users guides. 2022. https://nonmem.iconplc.com/nonmem743/guides.

Lindbom L, Pihlgren P, Jonsson EN. PsN-Toolkit—a collection of computer intensive statistical methods for non-linear mixed effect modeling using NONMEM. Comput Methods Programs Biomed. 2005;79(3):241–57.

Article  PubMed  Google Scholar 

Keizer RJ, Karlsson MO, Hooker A. Modeling and simulation workbench for NONMEM: tutorial on Pirana, PsN, and Xpose. CPT Pharmacometrics Syst Pharmacol. 2013;2(6): e50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pétricoul O, Cosson V, Fuseau E, Marchand M. Population models for drug absorption and enterohepatic recycling. In: Ette E, Williams P, editors. Pharmacometrics: the science of quantitative pharmacology. Hoboken: Wiley; 2006. p. 345–82.

Google Scholar 

Beal SL. Ways to fit a PK model with some data below the quantification limit. J Pharmacokinet Pharmacodyn. 2001;28(5):481–504.

Article  CAS  PubMed  Google Scholar 

Peters AM, Snelling HL, Glass DM, Bird NJ. Estimation of lean body mass in children. Br J Anaesth. 2011;106(5):719–23.

Article  CAS  PubMed  Google Scholar 

Du Boius D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. Nutrition. 1989;5(5):303–11.

Google Scholar 

O’Hanlon CJ, Holford N, Sumpter A, Al-Sallami HS. Consistent methods for fat-free mass, creatinine clearance, and glomerular filtration rate to describe renal function from neonates to adults. CPT Pharmacometrics Syst Pharmacol. 2023;12(3):401–12.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Anderson BJ, Holford NH. Mechanism-based concepts of size and maturity in pharmacokinetics. Annu Rev Pharmacol Toxicol. 2008;48:303–32.

Article  CAS  PubMed  Google Scholar 

Holford N, Heo YA, Anderson B. A pharmacokinetic standard for babies and adults. J Pharm Sci. 2013;102(9):2941–52.

Article  CAS  PubMed  Google Scholar 

Byon W, Smith MK, Chan P, Tortorici MA, Riley S, Dai H, et al. Establishing best practices and guidance in population modeling: an experience with an internal population pharmacokinetic analysis guidance. CPT Pharmacometrics Syst Pharmacol. 2013;2(7): e51.

Article  CAS  PubMed  Google Scholar 

Jonsson EN, Hooker A. Xpose 4 Bestiary.

Bergstrand M, Hooker AC, Wallin JE, Karlsson MO. Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models. AAPS J. 2011;13(2):143–51.

Article  PubMed  PubMed Central  Google Scholar 

Gerhart JG, Carreno FO, Edginton AN, Sinha J, Perrin EM, Kumar KR, et al. Development and evaluation of a virtual population of children with obesity for physiologically based pharmacokinetic modeling. Clin Pharmacokinet. 2022;61(2):307–20.

Article  CAS  PubMed  Google Scholar 

Goyal RK, Cristofaro V, Sullivan MP. Rapid gastric emptying in diabetes mellitus: pathophysiology and clinical importance. J Diabetes Complications. 2019;33(11): 107414.

Article  PubMed  PubMed Central  Google Scholar 

Tran A, Rey E, Pons G, Pariente-Khayat A, D’Athis P, Sallerin V, et al. Pharmacokinetic-pharmacodynamic study of oral lansoprazole in children. Clin Pharmacol Ther. 2002;71(5):359–67.

Article  CAS  PubMed  Google Scholar 

El Rouby N, Lima JJ, Johnson JA. Proton pump inhibitors: from CYP2C19 pharmacogenetics to precision medicine. Expert Opin Drug Metab Toxicol. 2018;14(4):447–60.

Article  PubMed  PubMed Central  Google Scholar